Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02898597 · ClinicalTrials.gov registry record · NA
Smoking Cessation Intervention for Women Living With HIV
A NA study, sponsored by University of Massachusetts, Boston.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT02898597 is a NA study that has completed, run by University of Massachusetts, Boston. The registered enrollment target is 49 participants.
The verdict
NCT02898597, a NA study, has completed, sponsored by University of Massachusetts, Boston.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
As people with HIV/AIDS live longer, the burden of non-AIDS-related health problems such as cardiovascular diseases and cancers on these people have consistently increased. Smoking is one of the major contributing factors to these health problems and rates of cigarette smoking in this group are substantially higher than those of the general population: 40-70% vs. 17-10%. Especially, women living with HIV/AIDS seem to be more susceptible to the negative consequence of smoking than their male counterparts. They are also less likely to see tobacco dependence treatment for dual stigma associated with both conditions: HIV infection and nicotine addiction. This is a pilot study to develop smoking cessation intervention for these women.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02898597
The ClinicalTrials.gov registry entry for NCT02898597 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.
NCT02898597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02898597 about?
NCT02898597 is a clinical study titled "Smoking Cessation Intervention for Women Living With HIV". As people with HIV/AIDS live longer, the burden of non-AIDS-related health problems such as cardiovascular diseases and cancers on these people have consistently increased. Smoking is one of the major contributing factors to these health problems and rates of cigarette smoking in this group are subs...
What is the current status of trial NCT02898597?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2016-06-01. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT02898597?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02898597?
This trial is sponsored by University of Massachusetts, Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.